naltrexone has been researched along with melatonin in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.67) | 18.7374 |
1990's | 9 (37.50) | 18.2507 |
2000's | 6 (25.00) | 29.6817 |
2010's | 5 (20.83) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Conti, A; Haran-Ghera, N; Maestroni, GJ | 1 |
Dall'ara, A; Korneva, EA; Lesnikov, VA; Pierpaoli, W | 1 |
Drela, N; Głuchowska, B; Kowalczyk, R; Kozłowska, E; Lech, B; Midura, M; Skwarło-Sońta, K; Thaela, MJ | 1 |
Appenzeller, O; Lewy, AJ; Peake, GT; Qualls, CR; Strassman, RJ | 1 |
Conti, A; Maestroni, GJ | 1 |
Conti, A; Maestroni, GJ; Pierpaoli, W | 2 |
Rault, B; Saiag, B; Shacoori, V | 1 |
Iacono, RP; Sandyk, R | 1 |
Gillberg, C | 1 |
Girre, A; Lemay, V; Rault, B; Saïag, B; Shacoori, V | 1 |
Conti, A; Galli, P; Hertens, E; Maestroni, GJ; Pedrinis, E | 1 |
Maestroni, GJ; Pedrinis, E; Zammaretti, F | 1 |
Agrewala, JN; Kulkarni, SK; Raghavendra, V | 1 |
Agrewala, JN; Kulkarni, SK; Raghavendra, V; Singh, V | 1 |
Conti, A; Kozlov, V; Laudon, M; Lissoni, P; Maestroni, G; Malugani, F; Malysheva, O | 1 |
Moore, CB; Siopes, TD | 1 |
Dziwinski, T; Majewski, P; Pawlak, J; Skwarlo-Sonta, K; Waloch, M | 1 |
Ambriz-Tututi, M; Araiza-Saldaña, CI; Arreola-Espino, R; Caram-Salas, NL; Granados-Soto, V; Mixcoatl-Zecuatl, T; Rocha-González, HI; Urquiza-Marín, H | 1 |
Lissoni, P; Rovelli, F | 1 |
Howland, RH | 1 |
Haldar, C; Mukherjee, A | 1 |
2 review(s) available for naltrexone and melatonin
Article | Year |
---|---|
Principles of psychoneuroendocrinoimmunotherapy of cancer.
Topics: 5-Methoxytryptamine; Antineoplastic Combined Chemotherapy Protocols; Cannabinoid Receptor Modulators; Humans; Immunotherapy; Interleukin-2; Melatonin; Naltrexone; Neoplasms; Neurosecretory Systems | 2012 |
Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
Topics: Anti-Obesity Agents; Bupropion; Drug Combinations; Humans; Liraglutide; Melatonin; Naltrexone; Obesity; Psychotropic Drugs; Weight Gain | 2015 |
1 trial(s) available for naltrexone and melatonin
Article | Year |
---|---|
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system.
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Renal Cell; Digestive System Neoplasms; Female; Humans; Injections, Subcutaneous; Interleukin-2; Kidney Neoplasms; Male; Melatonin; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pilot Projects | 2002 |
21 other study(ies) available for naltrexone and melatonin
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Role of pineal melatonin and melatonin-induced-immuno-opioids in murine leukemogenesis.
Topics: Animals; Cell Transformation, Neoplastic; Female; Leukemia, Experimental; Melatonin; Mice; Mice, Inbred C57BL; Naltrexone; Pineal Gland; Radiation Leukemia Virus; Survival Rate | 1992 |
The involvement of pineal gland and melatonin in immunity and aging: II. Thyrotropin-releasing hormone and melatonin forestall involution and promote reconstitution of the thymus in anterior hypothalamic area (AHA)-lesioned mice.
Topics: Aging; Animals; Female; Hypothalamus; Lymphocytes; Melatonin; Mice; Naltrexone; Pineal Gland; Stereotaxic Techniques; Thymus Gland; Thyrotropin-Releasing Hormone | 1992 |
Exogenous melatonin modifies the circadian rhythm but does not increase the level of some immune parameters in the chicken.
Topics: Agglutination; Animals; Chickens; Circadian Rhythm; Female; Immunity; Injections; Leukocyte Count; Lymphoid Tissue; Male; Melatonin; Mice; Mice, Inbred BALB C; Muramidase; Naltrexone; Organ Size; Random Allocation | 1992 |
Increase in plasma melatonin, beta-endorphin, and cortisol after a 28.5-mile mountain race: relationship to performance and lack of effect of naltrexone.
Topics: Adult; beta-Endorphin; Female; Humans; Hydrocortisone; Male; Melatonin; Middle Aged; Naltrexone; Physical Exertion; Radioimmunoassay; Regression Analysis; Running | 1989 |
Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin.
Topics: Adjuvants, Immunologic; Animals; beta-Endorphin; Body Weight; Circadian Rhythm; Dynorphins; Erythrocytes; Female; Hemolytic Plaque Technique; Melatonin; Mice; Mice, Inbred BALB C; Naltrexone; Organ Size; Prednisolone; Restraint, Physical; Stress, Psychological; Thymus Gland | 1989 |
Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism.
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Circadian Rhythm; Dose-Response Relationship, Immunologic; Female; Hemolytic Plaque Technique; Melatonin; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C57BL; Naltrexone; Pineal Gland | 1987 |
Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism.
Topics: Acute Disease; Animals; Antibody Formation; Endorphins; Female; Immune Tolerance; Melatonin; Mice; Mice, Inbred BALB C; Naltrexone; Pineal Gland; Stress, Psychological; Thymus Gland | 1988 |
Melatonin modifies prolactin release induced by opiate antagonists in male rats.
Topics: Animals; Injections, Subcutaneous; Male; Melatonin; Naloxone; Naltrexone; Narcotic Antagonists; Prolactin; Quaternary Ammonium Compounds; Rats; Rats, Wistar | 1995 |
Naltrexone attenuates the antiparkinsonian effects of picoTesla range magnetic fields.
Topics: Adult; Electromagnetic Fields; Humans; Male; Melatonin; Naltrexone; Opioid Peptides; Parkinson Disease; Pineal Gland; Psychomotor Performance | 1994 |
Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians.
Topics: Autistic Disorder; Brain; Endorphins; Humans; Infant, Newborn; Melatonin; Naloxone; Naltrexone; Self-Injurious Behavior; Serotonin | 1995 |
Effects of melatonin in vivo upon luteinizing hormone and prolactin releases induced by opiate receptor antagonists in adult male rats.
Topics: Animals; Luteinizing Hormone; Male; Melatonin; Naloxone; Naltrexone; Narcotic Antagonists; Prolactin; Quaternary Ammonium Compounds; Rats; Rats, Wistar | 1996 |
Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromatography, Gel; Chromatography, High Pressure Liquid; Drug Combinations; Dynorphins; Electrophoresis, Polyacrylamide Gel; Female; Hematopoietic System; Immunoblotting; Interleukin-4; Melatonin; Mice; Mice, Inbred C57BL; Molecular Weight; Naltrexone; Narcotic Antagonists; T-Lymphocytes, Helper-Inducer | 1996 |
Hematopoietic effect of melatonin involvement of type 1 kappa-opioid receptor on bone marrow macrophages and interleukin-1.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Dynorphins; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Hematopoiesis; Immunohistochemistry; Interleukin-1; Macrophages; Melatonin; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Oligodeoxyribonucleotides, Antisense; Receptors, Opioid, kappa | 1999 |
Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Behavior, Animal; Dexamethasone; Hyperalgesia; Lipopolysaccharides; Macrophages, Peritoneal; Male; Melatonin; Mice; Mice, Inbred BALB C; Naltrexone; Nitric Oxide; Pain Measurement; Pain Threshold; Tumor Necrosis Factor-alpha | 2000 |
Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists.
Topics: Animals; Cell Line; Central Nervous System Agents; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Flumazenil; GABA-A Receptor Antagonists; Hybridomas; Immunoglobulin G; Isoquinolines; Melatonin; Mice; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Ovalbumin; Peripheral Nervous System Agents; Receptors, Opioid, mu; Th2 Cells | 2001 |
Melatonin enhances cellular and humoral immune responses in the Japanese quail (Coturnix coturnix japonica) via an opiatergic mechanism.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Coturnix; Female; Immunity, Cellular; Melatonin; Naltrexone; Narcotic Antagonists; Photoperiod; Receptors, Opioid | 2003 |
Anti-inflammatory and opioid-mediated effects of melatonin on experimental peritonitis in chickens.
Topics: Adjuvants, Immunologic; Animals; beta-Endorphin; Cell Proliferation; Chickens; Disease Models, Animal; Enkephalins; Gene Expression; Macrophages, Peritoneal; Male; Melatonin; Naltrexone; Narcotic Antagonists; Opioid Peptides; Peritonitis; Pro-Opiomelanocortin; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Thioglycolates | 2005 |
Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Topics: Analgesics; Animals; Behavior, Animal; Diabetes Mellitus, Experimental; Female; Formaldehyde; Guanidines; Indoles; Melatonin; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Postural Balance; Rats; Rats, Wistar; Receptor, Melatonin, MT2 | 2007 |
Effect of Naltrexone on photoperiodic regulation of testicular steroidogenesis in adult golden hamster, Mesocricetus auratus.
Topics: Age Factors; Animals; beta-Endorphin; Circadian Rhythm; Cricetinae; Gonadal Steroid Hormones; Leydig Cells; Male; Melatonin; Mesocricetus; Naltrexone; Photoperiod; Reproduction; Testis; Testosterone | 2016 |